Project Grant R44HD112243
Award Date
9/25/23
Completion Date
8/31/26
Dollars Obligated
$1.2M
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Scottsdale, AZ 85259, USA
Similar Awards
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $1,000,000.00 to Sequitur Health Corp to develop a point-of-care device that can accurately measure metabolite levels from a single drop of blood. This will enable patients with rare metabolic disorders and their caregivers to monitor metabolite levels at home, potentially reducing the risk...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award for $997,142 aims to develop a rapid phenylalanine blood level monitor for patients with phenylketonuria (PKU), a lifelong genetic disorder. The product consists of a test strip and device that can provide frequent, accessible monitoring of phenylalanine levels from a finger prick to improve disease management and patient outcomes. The project focuses on optimizing the...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $990,990 to Integrated Medical Sensors Inc. to optimize the manufacturing and quality framework for their miniaturized continuous glucose monitoring (CGM+) platform. The CGM+ system utilizes a semiconductor-based electrochemical sensor designed to monitor glucose, ketones, temperature,...
This federal Project Grant award of $170,678 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program supports research to develop continuous electrochemical sensors for monitoring large analytes such as proteins and peptides in vivo. The primary objectives are to: 1) adapt promising preliminary results in redox quenching sensing to be compatible...
This $150,000 federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), aims to develop a personalized therapeutic drug monitoring (PTDM) system. The key objectives are to: Develop a personalized drug titration pharmacokinetic (PK) model, 2) Create electrochemistry assays for measuring anti-seizure drug levels in saliva,...
This $319,990 Project Grant, awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to investigate the use of continuous glucose monitoring (CGM) to personalize medical nutrition therapy for improving glycemic control in individuals with type 2 diabetes mellitus (T2DM). The 12-week randomized controlled trial will enroll 72 adult participants with T2DM to compare...
This Project Grant award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $550,000 to The Johns Hopkins University to develop a remote monitoring system to reduce infections in patients undergoing peritoneal dialysis (PD). The goal is to create a medical device that can enable high-frequency, real-time monitoring of cellular biomarkers in dialysate fluid, allowing for faster detection and diagnosis of...
This $400,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development, refinement, and evaluation of a customized version of the "MyTrials" remote biomarker capture system to support decentralized clinical trials for substance use disorders (SUDs). The project aims to address key limitations in the use of remote biomarker collection approaches for SUD research by integrating such...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded a $375,750 Project Grant (R21EB036367) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a wearable monitor that can detect early signs of decompensation in cardiac failure patients. The project aims to build and validate a multi-wavelength...
This $255,706 National Science Foundation SBIR Phase I Project Grant to Metfora LLC supports the development of a novel multiplexed metabolite diagnostic blood test for early detection of chronic diseases. The NSF Technology, Innovation, and Partnerships program aims to advance science and engineering solutions to national challenges through innovation and partnerships. Specifically, Metfora will use mass spectrometry and artificial intelligence to analyze specific panels of circulating...